| 臺大學術典藏 |
2020-06-30T08:15:54Z |
Comparison of transforming growth factor-beta1 and lovastatin on differentiating mesenchymal stem cells toward nucleus pulposus-like phenotype: An in vitro cell culture study
|
Yang S.-H.;Yang K.-C.;Chen C.-W.;Huang T.-C.;Sun Y.-H.;Ming-Hsiao Hu; Yang S.-H.; Yang K.-C.; Chen C.-W.; Huang T.-C.; Sun Y.-H.; MING-HSIAO HU |
| 臺大學術典藏 |
2020-06-30T06:14:01Z |
Two fatal cases of Veillonella bacteremia [2]
|
Liu J.W.;Wu J.J.;Wang L.R.;Lee-Jene Teng;Huang T.C.; Liu J.W.; Wu J.J.; Wang L.R.; LEE-JENE TENG; Huang T.C. |
| 臺大學術典藏 |
2020-06-11T06:58:55Z |
End-fire Quasi-Yagi antennas with pattern diversity on LTCC technology for 5G mobile communications
|
Huang, T.-C.;Hsu, Y.-W.;Lin, Y.-C.; Huang, T.-C.; Hsu, Y.-W.; Lin, Y.-C.; YI-CHENG LIN |
| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H;Lu Y.S;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Chih-Hsin Yang;Cheng A.L.; Yeh K.H; Lu Y.S; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; CHIH-HSIN YANG; Cheng A.L. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Lin C.-C; Huang T.-C; Yang P.-C; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Cheng A.-L; Hu F.-C; Kuo S.-H; Hsu C; Chih-Hsin Yang;Yang P.-C;Huang T.-C;Lin C.-C;Yu C.-J;Shih J.-Y;Cheng A.-L;Hu F.-C;Kuo S.-H;Hsu C |
| 臺大學術典藏 |
2020-05-25T07:35:30Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C; Kuo S.-H; Hu F.-C; Cheng A.-L; Shih J.-Y; Yu C.-J; Chia-Chi Lin; Huang T.-C; Yang P.-C; Yang C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:24Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W; Chia-Chi Lin; Huang T.-C; Cheng A.-L; Yeh K.-H; Hsu C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:20Z |
Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer
|
Huang T.-C; Hsu C.-H; Chia-Chi Lin; Tu Y.-K. |
| 臺大學術典藏 |
2020-05-25T07:35:20Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C; Huang T.-C; Chia-Chi Lin; Hsieh M.-S; Chang C.-H; Huang P.-M; Lee J.-M; Hsu F.-M; Cheng J.C.-H; Wang H.-P; Yeh K.-H; Cheng A.-L; Hsu C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:12Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C; Chia-Chi Lin; Huang T.-C; Huang P.-M; Kuo H.-Y; Chang C.-H; Wang C.-C; Cheng J.C.-H; Yeh K.-H; Hsu C.-H; Lee J.-M. |
| 臺大學術典藏 |
2020-05-25T07:35:05Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C; Chia-Chi Lin; Wu Y.-C; Chia-Hsien Cheng J; Lee J.-M; Wang H.-P; Huang P.-M; Hsu F.-M; Yeh K.-H; Cheng A.-L; Tzen K.-Y; Hsu C.-H.; Hsu C.-H.;Tzen K.-Y;Cheng A.-L;Yeh K.-H;Hsu F.-M;Huang P.-M;Wang H.-P;Lee J.-M;Chia-Hsien Cheng J;Wu Y.-C;Chia-Chi Lin;Huang T.-C |
| 臺大學術典藏 |
2020-05-25T06:52:09Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H;Yen-Shen Lu;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Yang C.H;Cheng A.L.; Yeh K.H; YEN-SHEN LU; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; Yang C.H; Cheng A.L. |
| 臺大學術典藏 |
2020-05-25T02:45:35Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C; Huang T.-C; Lin C.-C; Hsieh M.-S; Chang C.-H; Huang P.-M; Lee J.-M; Feng-Ming Hsu; Cheng J.C.-H; Wang H.-P; Yeh K.-H; Cheng A.-L; Hsu C.-H. |
| 臺大學術典藏 |
2020-05-24T05:40:02Z |
A novel GnRH-antagonist protocol by switching to medroxyprogesterone when patients being at risk of ovarian hyperstimulation syndrome during ovarian stimulation
|
Huang T.-C.; Lin Y.-H.; Pan S.-P.; YI-AN TU; Huang C.-C.; Chen M.-J.; Hwang J.-L.; Chen S.-U. |
| 臺大學術典藏 |
2020-05-19T01:52:57Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Cheng A.-L.; Yeh K.-H.; Wang H.-P.; Cheng J.C.-H.; Hsu F.-M.; Lee J.-M.; PEI-MING HUANG; Chang C.-H.; Hsieh M.-S.; Lin C.-C.; Huang T.-C.; Guo J.-C.; Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Pei-Ming Huang;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Yeh K.-H.;Cheng A.-L.;Hsu C.-H. |
| 臺大學術典藏 |
2020-05-19T01:52:54Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Pei-Ming Huang;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Hsu C.-H.;Lee J.-M.; Guo J.-C.; Lin C.-C.; Huang T.-C.; PEI-MING HUANG; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; Lee J.-M. |
| 臺大學術典藏 |
2020-05-15T07:01:39Z |
Performance of a low-cost earthquake early warning system (P-ALErt) and shake map production during the 2018 M w 6.4 Hualien, Taiwan, earthquake
|
Wu, Y.-M.; Mittal, H.; Huang, T.-C.; Yang, B.M.; Jan, J.-C.; Chen, S.K.; YIH-MIN WU |
| 臺大學術典藏 |
2020-05-15T07:01:38Z |
A robust algorithm for automatic P-wave arrival-time picking based on the local extrema scalogram
|
Huang, T.-C.;Wu, Y.-M.; Huang, T.-C.; Wu, Y.-M.; YIH-MIN WU |
| 臺大學術典藏 |
2020-04-28T07:25:18Z |
Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer
|
Huang T.-C.;Chih-Hung Hsu;Lin C.-C.;Tu Y.-K.; Huang T.-C.; CHIH-HUNG HSU; Lin C.-C.; Tu Y.-K. |
| 臺大學術典藏 |
2020-04-28T07:25:17Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; CHIH-HUNG HSU; Lin C.-C.; Huang T.-C.; Guo J.-C.; Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Yeh K.-H.;Cheng A.-L.;Chih-Hung Hsu |
| 臺大學術典藏 |
2020-04-28T07:25:12Z |
On predicting clinical response to chemoradiotherapy in esophageal squamous cell carcinoma: Additional evaluation by magnetic resonance imaging may help
|
Huang T.-C.;Chih-Hung Hsu; Huang T.-C.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2020-04-28T07:25:12Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
CHIH-HUNG HSU; Yeh K.-H.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Guo J.-C.; Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Chih-Hung Hsu;Lee J.-M.; Lee J.-M. |
| 臺大學術典藏 |
2020-04-28T07:25:11Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; Tzen K.-Y.; CHIH-HUNG HSU; Lin C.-C.; Wu Y.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Chih-Hung Hsu |
| 臺大學術典藏 |
2020-04-27T08:45:07Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Chia-Hsien Cheng;Yeh K.-H.;Hsu C.-H.;Lee J.-M.; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; CHIA-HSIEN CHENG; Yeh K.-H.; Hsu C.-H.; Lee J.-M. |
| 臺大學術典藏 |
2020-04-10T12:51:24Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F.; Chiun Hsu; Chen C.-Y.; Tang J.-L.; Ko B.-S.; Huang T.-C.; Huang T.-C.;Ko B.-S.;Tang J.-L.;Chiun Hsu;Chen C.-Y.;Tsay W.;Huang S.-Y.;Yao M.;Chen Y.-C.;Shen M.-C.;Wang C.-H.;Tien H.-F. |